PT-001 + PT-005
- Generic Name
- PT-001 + PT-005
Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)
Phase 3
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: GP MDIDrug: Placebo MDI
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Pearl Therapeutics, Inc.
- Target Recruit Count
- 2103
- Registration Number
- NCT01854645
- Locations
- 🇳🇿
Pearl Investigative Site, Tauranga, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath